We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $31.29 in the latest trading session, marking a -2.61% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.49%. At the same time, the Dow added 0.71%, and the tech-heavy Nasdaq gained 2.26%.
Shares of the company have appreciated by 0.28% over the course of the past month, outperforming the Finance sector's loss of 2.25%, and the S&P 500's gain of 0.1%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.15 per share. This would mark year-over-year growth of 71.7%. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of $1.74 per share and revenue of $18.81 billion. These results would represent year-over-year changes of +202.96% and +60.77%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 12.96% higher within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 18.43. This signifies a premium in comparison to the average Forward P/E of 10.08 for its industry.
We can also see that OSCR currently has a PEG ratio of 0.37. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Insurance - Multi line industry was having an average PEG ratio of 0.93.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 80, finds itself in the top 33% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
Oscar Health, Inc. (OSCR - Free Report) closed at $31.29 in the latest trading session, marking a -2.61% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.49%. At the same time, the Dow added 0.71%, and the tech-heavy Nasdaq gained 2.26%.
Shares of the company have appreciated by 0.28% over the course of the past month, outperforming the Finance sector's loss of 2.25%, and the S&P 500's gain of 0.1%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.15 per share. This would mark year-over-year growth of 71.7%. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of $1.74 per share and revenue of $18.81 billion. These results would represent year-over-year changes of +202.96% and +60.77%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 12.96% higher within the past month. Oscar Health, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 18.43. This signifies a premium in comparison to the average Forward P/E of 10.08 for its industry.
We can also see that OSCR currently has a PEG ratio of 0.37. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Insurance - Multi line industry was having an average PEG ratio of 0.93.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 80, finds itself in the top 33% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.